Optomed Oyj - Major shareholder announcements

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed PlcStock Exchange Release2 July 2024 at 10.45, Helsinki

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding
change in holdings

Optomed Plc (“Optomed” or the “Company”) has received a notification in
accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act
(as amended, the “SMA”) from Sp Rahastoyhtiö Oy (“Notifier”). According to the
notification, the total holdings in Optomed shares and votes held the investment
funds of Sp-Rahastoyhtiö (Säästöpankki Pienyhtiöt, Säästöpankki Kotimaaa)is 6.51
per cent of all of the registered shares in Optomed on 1 July 2024.

The total number of the Company's registered shares amounts to 19,630,397
shares. Each share entitles to one vote.

The total position of Notifier subject to the notification:

+----------------+----------+------------------+-----+----------------------+
|                |% of      |% of shares and   |Total|Total number of shares|
|                |shares and|voting rights     |of   |and voting rights of  |
|                |voting    |through financial |both |issuer                |
|                |rights    |instruments (total|in % |                      |
|                |(total    |of B)             |(A+B)|                      |
|                |of A)     |                  |     |                      |
+----------------+----------+------------------+-----+----------------------+
|Resulting       |6.51 %    |                  |6.51 |19630 397             |
|situation on the|          |                  |%    |                      |
|date on         |          |                  |     |                      |
|which threshold |          |                  |     |                      |
|was crossed or  |          |                  |     |                      |
|reached         |          |                  |     |                      |
+----------------+----------+------------------+-----+----------------------+
|Position of     |          |                  |     |                      |
|previous        |          |                  |     |                      |
|notification    |          |                  |     |                      |
|(if applicable) |          |                  |     |                      |
+----------------+----------+------------------+-----+----------------------+

Notified details of the resulting situation on the date on which the threshold
was crossed or reached:

A: Shares and voting rights

+------------+-----------------+----------------+-----------------+-----------+
|Class/type  |Number of shares and voting rights|% of shares and voting rights|
|of shares   |                                  |                             |
|            |                                  |                             |
|ISIN code   |                                  |                             |
+------------+-----------------+----------------+-----------------+-----------+
|Direct      |Indirect         |Direct          |Indirect         |
|(SMA 9:5)   |(SMA 9:6 and 9:7)|(SMA 9:5)       |(SMA 9:6 and 9:7)|
+------------+-----------------+----------------+-----------------+-----------+
|FI4000410881|1278 107         |                |6.51%            |           |
+------------+-----------------+----------------+-----------------+-----------+
|SUBTOTAL A  |1278 107                          |6.51 %                       |
+------------+-----------------+----------------+-----------------+-----------+

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld fundus cameras with
software and artificial intelligence with the aim to transform the diagnostic
process of blinding eye diseases, such as rapidly increasing diabetic
retinopathy. In its business Optomed focuses on eye screening devices and
software solutions related R&D in Finland and sales through different channels
in over 60 countries.

www.optomed.com